Literature DB >> 33761344

Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.

Bas Brouwers1, Edson Mendes de Oliveira1, Maria Marti-Solano2, Fabiola B F Monteiro1, Suli-Anne Laurin3, Julia M Keogh1, Elana Henning1, Rebecca Bounds1, Carole A Daly4, Shane Houston4, Vikram Ayinampudi1, Natalia Wasiluk1, David Clarke1, Bianca Plouffe4, Michel Bouvier3, M Madan Babu5, I Sadaf Farooqi6, Jacek Mokrosiński1.   

Abstract

The Melanocortin-4 Receptor (MC4R) plays a pivotal role in energy homeostasis. We used human MC4R mutations associated with an increased or decreased risk of obesity to dissect mechanisms that regulate MC4R function. Most obesity-associated mutations impair trafficking to the plasma membrane (PM), whereas obesity-protecting mutations either accelerate recycling to the PM or decrease internalization, resulting in enhanced signaling. MC4R mutations that do not affect canonical Gαs protein-mediated signaling, previously considered to be non-pathogenic, nonetheless disrupt agonist-induced internalization, β-arrestin recruitment, and/or coupling to Gαs, establishing their causal role in severe obesity. Structural mapping reveals ligand-accessible sites by which MC4R couples to effectors and residues involved in the homodimerization of MC4R, which is disrupted by multiple obesity-associated mutations. Human genetic studies reveal that endocytosis, intracellular trafficking, and homodimerization regulate MC4R function to a level that is physiologically relevant, supporting the development of chaperones, agonists, and allosteric modulators of MC4R for weight loss therapy.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GPCRs; Gα(s); MC4R; MSH; melanocortin; obesity; therapy; weight loss; β-arrestin

Mesh:

Substances:

Year:  2021        PMID: 33761344      PMCID: PMC7994375          DOI: 10.1016/j.celrep.2021.108862

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  70 in total

Review 1.  GPCR signaling along the endocytic pathway.

Authors:  Roshanak Irannejad; Mark von Zastrow
Journal:  Curr Opin Cell Biol       Date:  2013-12-28       Impact factor: 8.382

2.  Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.

Authors:  Karine Clément; Erica van den Akker; Jesús Argente; Allison Bahm; Wendy K Chung; Hillori Connors; Kathleen De Waele; I Sadaf Farooqi; Julie Gonneau-Lejeune; Gregory Gordon; Katja Kohlsdorf; Christine Poitou; Lia Puder; James Swain; Murray Stewart; Guojun Yuan; Martin Wabitsch; Peter Kühnen
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10-30       Impact factor: 32.069

3.  The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants.

Authors:  Eirini Meimaridou; Sakina B Gooljar; Nalini Ramnarace; Lucia Anthonypillai; Adrian J L Clark; J Paul Chapple
Journal:  Mol Endocrinol       Date:  2011-06-30

4.  Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to α-melanocyte-stimulating hormone (α-MSH).

Authors:  Faith K McDaniel; Brent M Molden; Sameer Mohammad; Giovanna Baldini; Lakisha McPike; Paola Narducci; Susana Granell; Giulia Baldini
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

5.  Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization.

Authors:  May M Paing; Christopher A Johnston; David P Siderovski; Joann Trejo
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

7.  Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.

Authors:  Anke Hinney; Thomas Bettecken; Patrick Tarnow; Harald Brumm; Kathrin Reichwald; Peter Lichtner; André Scherag; Thuy Trang Nguyen; Pia Schlumberger; Winfried Rief; Caren Vollmert; Thomas Illig; H-Erich Wichmann; Helmut Schäfer; Matthias Platzer; Heike Biebermann; Thomas Meitinger; Johannes Hebebrand
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 5.958

8.  Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.

Authors:  Robert Haws; Sheila Brady; Elisabeth Davis; Kristina Fletty; Guojun Yuan; Gregory Gordon; Murray Stewart; Jack Yanovski
Journal:  Diabetes Obes Metab       Date:  2020-07-22       Impact factor: 6.577

9.  A new mechanism of allostery in a G protein-coupled receptor dimer.

Authors:  J Robert Lane; Prashant Donthamsetti; Jeremy Shonberg; Christopher J Draper-Joyce; Samuel Dentry; Mayako Michino; Lei Shi; Laura López; Peter J Scammells; Ben Capuano; Patrick M Sexton; Jonathan A Javitch; Arthur Christopoulos
Journal:  Nat Chem Biol       Date:  2014-08-10       Impact factor: 15.040

View more
  4 in total

1.  Detecting genetic epistasis by differential departure from independence.

Authors:  Ruby Sharma; Zeinab Sadeghian Tehrani; Sajal Kumar; Mingzhou Song
Journal:  Mol Genet Genomics       Date:  2022-05-23       Impact factor: 3.291

Review 2.  Genetic variation in satiety signaling and hypothalamic inflammation: merging fields for the study of obesity.

Authors:  Alexandria Maria Szalanczy; Chia-Chi Chuang Key; Leah Catherine Solberg Woods
Journal:  J Nutr Biochem       Date:  2021-12-20       Impact factor: 6.048

Review 3.  Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.

Authors:  Munazza Tamkeen Fatima; Ikhlak Ahmed; Khalid Adnan Fakhro; Ammira Sarah Al-Shabeeb Akil
Journal:  Diabetes Obes Metab       Date:  2022-01-11       Impact factor: 6.408

Review 4.  Obesity, POMC, and POMC-processing Enzymes: Surprising Results From Animal Models.

Authors:  Iris Lindberg; Lloyd D Fricker
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.